💙 🔷 Not impressed by Big Tech in Q3? Explore these Blue Chip Bargains insteadUnlock them all

PRESS DIGEST- New York Times business news - Oct 27

Published 2015-10-27, 12:44 a/m
© Reuters.  PRESS DIGEST- New York Times business news - Oct 27
GM
-
GS
-
AMZN
-
BHC
-

Oct 27 (Reuters) - The following are the top stories on the
New York Times business pages. Reuters has not verified these
stories and does not vouch for their accuracy.

- A former Goldman Sachs Group Inc (N:GS) GS.N banker admitted
his guilt in taking confidential documents from an employee at
the Federal Reserve Bank of New York, who also agreed to plead
guilty.

- Valeant Pharmaceuticals (N:VRX) VRX.TO said in a conference call
that its accounting was legal in connection with the pharmacy,
Philidor Rx Services.

- President Joko Widodo of Indonesia met with President
Obama in Washington and said his country would eventually join
the Trans-Pacific Partnership.

- United Automobile Workers leaders from General Motors (N:GM)
GM.N plants nationwide will gather Wednesday in Detroit to
learn details of a tentative agreement reached with GM late
Sunday that covers about 52,000 employees. If the union leaders
approve, the deal would next be voted on by GM's UAW members.

- Wal Mart Stores Inc WMT.N applied to federal regulators
on Monday for permission to test drones for home delivery and
for use at its distribution centers and stores. In pushing ahead
with drone technology, the company follows Amazon AMZN.O ,
which has been trumpeting its "Prime Air" drone delivery plans
since 2013.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.